As of January 22, 2025, Amneal Pharmaceuticals (AMRX) has a market cap of $3.92 billion USD. According to our data, Amneal Pharmaceuticals is ranked No.3060 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.92 B |
59.64%
|
Dec 31, 2024 | $2.45 B |
30.48%
|
Dec 29, 2023 | $1.88 B |
205.03%
|
Dec 30, 2022 | $0.62 B |
-58.46%
|
Dec 31, 2021 | $1.48 B |
4.81%
|
Dec 31, 2020 | $1.42 B |
-5.19%
|
Dec 31, 2019 | $1.49 B |
-64.38%
|
Dec 31, 2018 | $4.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Viatris
VTRS
|
$13.34 B |
5.848 M
|
USA
|
Perrigo
PRGO
|
$3.29 B |
-0.000 M
|
Ireland
|
Dr. Reddy's
RDY
|
$12.65 B |
0.123 B
|
India
|
Market Cap | = | AMRX Stock Price | * | AMRX Shares Outstanding |
= | $8.48 | * | 0.31 B | |
= | $3.92 B |